Clinical Trial: Remicade's Effects on RA
Links shared publicly online about this topic
Understanding Clinical Trials | ORAL Trials
oraltrials.com — “Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide. The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.” View full resource at oraltrials.com
Most Recently Shared on October 30, 2010 at 9:52 pm By:
madan kwatra Doctor and PhD
Understanding Clinical Trials | ORAL Trials http://t.co/qRNDHRV via @AddThis
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Anti-TNF Agents for the Treatment of Rheumatoid Arthritis - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on August 26, 2010 at 2:56 pm By:
Miriam E. Tucker Patient Expert
RT @NIAIDNews: #Rheumatoid #arthritis patients ages 18-75 needed to participate in NIAID treatment #clinicaltrial http://go.usa.gov/cwb
Clinical Trials Update: Sept. 10, 2010:
health.msn.com — “Clinical Trials Update: Sept. 10, 2010:” View full resource at health.msn.com
Most Recently Shared on September 10, 2010 at 4:25 pm By:
Clinical Trials Update: Sept. 10, 2010: http://on.msn.com/9kRaLJ
Clinical Trials Update: Sept. 21, 2009
health.msn.com — “Clinical Trials Update: Sept. 21, 2009” View full resource at health.msn.com
Most Recently Shared on September 21, 2009 at 5:58 pm By:
Clinical Trials Update: Sept. 21, 2009 http://bit.ly/gtBqs
REMICADE (infliximab) and Crohn's - Accent 1 Study
remicade.com — “Accent 1, the largest clinical trial ever conducted for Crohn's treatment, was designed to compare the effectiveness of REMICADE" (infliximab) over a 54-week period versus a single dose.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:30 am By:
Susan Scroggins Active Health Library and Health Advocate
The ACCENT I study showed that Remicade may offer Crohn's disease patients remission in as little as two weeks. http://bit.ly/9jqTHM
REMICADE (infliximab) and Crohn's - Accent 2 Study
remicade.com — “Accent 2, the largest clinical trial ever conducted for Crohn's treatment, was designed to compare the effectiveness of REMICADE" (infliximab) over a 54-week period versus a single dose.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:16 am By:
Susan Scroggins Active Health Library and Health Advocate
Approval for Remicade maintenance therapy in fistulizing Crohn’s disease was based on results of the ACCENT II study. http://bit.ly/c5C05g
Healthcare Professionals - ACCENT 2 Clinical Trial for Crohn's
remicade.com — “Accent 2, the largest clinical trial ever conducted for Crohn's treatment, was designed to compare the effectiveness of REMICADE" (infliximab) over a 54-week period versus a single dose.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:38 am By:
Susan Scroggins Active Health Library and Health Advocate
An overview of the ACCENT II clinical trial regarding fistulizing Crohn's & Remicade for health care professionals. http://bit.ly/cQyLxN
Healthcare Professionals - ACCENT 1 Clinical Trial for Crohn's
remicade.com — “Accent 1, the largest clinical trial ever conducted for Crohn's treatment, was designed to compare the effectiveness of REMICADE" (infliximab) over a 54-week period versus a single dose.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:54 am By:
An overview of the ACCENT I clinical trial for Remicade's use in treating Crohn's disease - for health professionals. http://bit.ly/csHst6
Advisers will review J&J's Remicade for pediatric colitis - Related Stories - AAP SmartBrief
smartbrief.com — “An FDA advisory committee is scheduled Thursday to evaluate Johnson and Johnson's Remicade for use in children with ulcerative colitis. In a preliminary review, the agency said a pediatric clinical trial for Remicade was not intended to demonstrate the drug's effectiveness. The FDA will ask adviser…” View full resource at smartbrief.com
Most Recently Shared on July 25, 2011 at 3:55 pm By:
Clara Song Pediatrician, Physician, and Doctor
Advisers will review J and J's Remicade for pediatric colitis http://t.co/jSBzWwz
Medical News: DDW: Two-Drug Combo Tops for Remission in Crohn's Disease - in Meeting Coverage, DDW from MedPage Today
medpagetoday.com — “CHICAGO -- Combining infliximab (Remicade) with azathioprine (Imuran) was more effective at maintaining remission in Crohn's disease for one year than either drug alone, researchers reported here.” View full resource at medpagetoday.com
Most Recently Shared on June 3, 2009 at 8:55 pm By:
CLINICAL TRIALS• DDW: Two-Drug Combo Tops for Remission in Crohn's Disease (CME/CE) http://tinyurl.com/ow2aw8
ENT Medical News about Ketoprofen Pain, Postoperative Molar, Third
mdlinx.com — “Preemptive effect of ketoprofen on postoperative pain following third molar surgery. A prospective, randomized, double-blinded clinical trial” View full resource at mdlinx.com
Most Recently Shared on June 25, 2010 at 4:07 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Preemptive effect of ketoprofen on postoperative pain following third molar surgery. A prospective, ra... http://bit.ly/bb6S0E #ENT #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
madan kwatra
Associate Professor, Duke University Medical Center
-
Miriam E. Tucker
Medical & public health journalist / Diabetes patient-expert / Senior Writer with Elsevier's International Medical News Group (@MedicalNewsNet).
-
msn
Advertisement
